NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England Offer reference number: CM/PHR/14/5446 Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend...